• Maria Bonou, Sophie Mavrogeni, Chris J Kapelios, Marina Skouloudi, Constantina Aggeli, Evangelos Cholongitas, George Papatheodoridis, and John Barbetseas.
• Department of Cardiology, Laiko General Hospital, 11527 Athens, Greece.
• Diagnostics (Basel). 2021 Jan 5; 11 (1).

AbstractCardiovascular (CV) complications represent the first non-graft-related cause of death and the third overall cause of death among patients undergoing liver transplantation (LT). History of coronary artery disease is related to increased CV mortality following LT. Although it is of paramount importance to stratify CV risk in pre-LT patients, there is no consensus regarding the choice of the optimal non-invasive cardiac imaging test. Algorithms proposed by scientific associations include non-traditional risk factors, which are associated with increased cardiac risk profiles. Thus, an individualized pre-LT evaluation protocol should be followed. As the average age of patients undergoing LT and the number of candidates continue to rise, the "3 W" questions still remain unanswered, Who, Which and When? Who should be screened for coronary artery disease (CAD), which screening modality should be used and when should the asymptomatic waitlisted patients repeat cardiac evaluation? Prospective studies with large sample sizes are warranted to define an algorithm that can provide better risk stratification and more reliable survival prediction.

7 keywords...

hide…